To: m. jacobs who wrote (7329 ) 1/30/2005 8:44:04 PM From: Jack Rayfield Read Replies (1) | Respond to of 8117 TIAX Awarded $730M Contract by the Department of Defense to Develop Prototype Reusable Sternal IO Device Mr. Jacobs Was Pyng in the running for this contract? If so do you know why it was awarded to TIAX and not Pyng? If this does not violate one of Pyng's several patents, I am not sure what protection the patents provides as I thought that Pyng pretty much had the sternal site for IO sewn up tight by patent protections? But apparently not. I tried to send this question to you by private reply but you apparently have me on Ignore so it would not go through.Note: Excerpted PR for relavent details related to Pyng TIAX Awarded $730M Contract by the Department of Defense to Produce A Prototype Reusable Intraosseous Infusion Device October 27, 2004 (Cambridge, MA) - TIAX, a leading collaborative product and technology development firm, announced today that it has been awarded three Phase II contracts by the U.S. Department of Defense (DoD) Small Business Innovation Research (SBIR) program. The contracts, totaling more than $2 million, will enable TIAX to continue its efforts in the development of three new technologies to assist soldiers in the battlefield; an intraosseous infusion device, a medical blood pack, and a wearable stress detection system. "We are honored to continue our partnership with the Department of Defense and delighted that our work on these projects will contribute to the safety and wellbeing of our armed forces," said Kenan Sahin, President of TIAX. "In addition to the role these technologies could play in helping our military, they may one day be used by first responders, emergency personnel, and critical staff to benefit the larger civilian population." The projects include:Reusable Intraosseous Infusion Device - Intraosseous infusion (an infusion directly in the marrow cavity of the human bone) is a rapid, reliable method of infusing critical resuscitation fluids into the vascular system when traditional IV cannot be administered. Under this $730,000 contract, TIAX will produce a prototype of a compact, portable device that enables quick vascular access through the sternum for soldiers wounded in battle situations. TIAX's design includes carriage of multiple needles so the system can be used several times and a driver/depth control system that simplifies usage in combat situations. The device may eventually be commercialized for use by emergency medical personnel in hospital trauma units